Skip to content
Screener

KORU Medical Systems KRMD Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$12.0MBeat by $427.4K
EPS$0.01Beat by $0.03
Revenue estimate$11.6M
EPS estimate-$0.02
“We delivered record revenue, improved gross margins and generated positive net income for the quarter, all of which demonstrate our ability to drive durable and profitable growth in the subcutaneous drug delivery market. We also acquired a technology asset, representing a strategic investment in connected monitoring potential to further enhance the patient experience and differentiate KORU's value proposition to our partners.”
Adam Kalbermatten

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$11.3M
EPS estimate-$0.02

Financials

Q2 2026

Income statement

See full
Revenue$12.0M+18.2%
Gross profit$7.8M+21.2%
Operating income$627.0K+301%
Net income$252.4K+222%
EPS (diluted)$0.01—

Balance sheet

See full
Cash & equivalents$8.3M+2.9%
Total debt$3.5M-0.3%
Total equity$18.1M+9.2%
Total assets$28.0M+9.6%

Cash flow

See full
Operating cash flow$216.1K+147%
CapEx$107.9K+274%
Free cash flow$108.2K+122%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$147.75M-19.3%
Enterprise value$142.92M-19.9%
P/S3.3×-1.7×

Profitability

See full
Gross margin62.4%-0.7pp
Operating margin-3.7%-1.5pp
Net margin-4%-1.6pp

Returns & leverage

See full
Return on equity-10.5%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.7×-0.2×

FAQ

When did KORU Medical Systems report Q2 2026 earnings?
KORU Medical Systems (KRMD) reported Q2 2026 earnings on August 5, 2026 after market close.
What were KORU Medical Systems's Q2 2026 revenue and EPS?
KORU Medical Systems reported revenue of $12.0M and eps of $0.01 for Q2 2026.
Did KORU Medical Systems beat estimates in Q2 2026?
Revenue beat the consensus estimate of $11.6M by $427.4K. EPS beat the consensus estimate of $-0.02 by $0.03.
How did KORU Medical Systems's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.2% from $10.2M a year earlier and eps grew 0.0% from $0.01.
Where can I find KORU Medical Systems's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001161697-26-000188) and the 10-Q periodic report (0001161697-26-000189) directly on SEC EDGAR. The filing index links above go to sec.gov.